Estimating case-fatality reduction from randomized screening trials
From MaRDI portal
Publication:2325021
DOI10.1515/EM-2018-0007zbMath1420.92057OpenAlexW2899909970WikidataQ128992277 ScholiaQ128992277MaRDI QIDQ2325021
Sudipta Saha, Olli Saarela, Zhihui Liu
Publication date: 12 September 2019
Published in: Epidemiologic Methods (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1515/em-2018-0007
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
Related Items (1)
Uses Software
Cites Work
- Bayesian inference for causal effects in randomized experiments with noncompliance
- Bayesian inference for causal effects: The role of randomization
- Identification of Causal Effects Using Instrumental Variables
- Statistics and Causal Inference
- Addressing complications of intention-to-treat analysis in the combined presence of all-or-none treatment-noncompliance and subsequent missing outcomes
- A Proportional Hazards Model for the Subdistribution of a Competing Risk
- Latent Subgroup Analysis of a Randomized Clinical Trial through a Semiparametric Accelerated Failure Time Mixture Model
This page was built for publication: Estimating case-fatality reduction from randomized screening trials